Trimodal therapy in muscle invasive bladder cancer management.

CONCLUSIONS: Published data and clinical experience strongly support trimodal therapy as an acceptable bladder sparing strategy in terms of oncological outcomes and quality of life in selected patients with MIBC. A strong need exists for specialized centers, to increase awareness among urologists, to discuss these options with patients and to stress the increased participation of patients and their families in treatment path decision-making. PMID: 33263367 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33263367?dopt=Abstract

Source: Minerva Urologica e Nefrologica - December 4, 2020 Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research